Search Results 41-50 of 16376 for anti-TNF drugs
... drugs (DMARDs) ... TNF-alpha inhibitors: Tumor necrosis factor (TNF)- ... Medications in this category include infliximab (Remicade) and etanercept (Enbrel).
The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...
Drugs and Supplements. Search prescription and over-the-counter drugs . ... Adalimumab-fkjp (subcutaneous route). Humalog. Also known as. Insulin lispro ...
The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...
Intolerance, loss response or failure to respond to treatment with at least one TNF-inhibitor within the previous 5 years; Washout of anti-TNF therapy for at ...
... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...
NSAIDs — If your symptoms are mild, nonsteroidal anti ... Disease-modifying antirheumatic drugs (DMARDs) — These drugs ... TNF-alpha inhibitors block this substance ...
Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep; 148 (3):661-667. View PubMed; Katz S, Kane SV. Myths and Misconceptions in the ...
... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Previous treatment with tocilizumab or etanercept. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.